Longevity investors look to add $200M to the table with new growth fund
Bold Capital Partners, a life sciences and deep tech investor, is raising a new fund to support biotechs and diagnostics makers focused on “healthy human …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
